Although the provision aimed at broadening coverage of anti-obesity medications garnered the most attention, the Biden administration’s last Medicare Advantage and Part D rule was full of under-the-radar provisions for the prescription drug benefits space.
Biden Admin’s Last Part D Rule Also Has Generic Drug Exclusion Comments, Prescription Payment Plan Tweaks
In the proposed rule, CMS said it would begin reviewing Part D plan formularies and utilization practices to see if programs include incentives to reduce costs, as well as offered suggestions for implementing the new Medicare Prescription Payment Plan.
